Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,417 | 120 | 95.7% |
| Education | $109.90 | 2 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $667.29 | 44 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $424.05 | 24 | $0 (2024) |
| ABBVIE INC. | $299.84 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $236.01 | 8 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $209.54 | 7 | $0 (2024) |
| Alkermes, Inc. | $184.87 | 5 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $150.50 | 8 | $0 (2024) |
| Axsome Therapeutics, Inc. | $124.99 | 1 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $94.91 | 4 | $0 (2024) |
| ITI, Inc. | $71.97 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,094 | 49 | Teva Pharmaceuticals USA, Inc. ($318.04) |
| 2023 | $975.47 | 55 | Teva Pharmaceuticals USA, Inc. ($337.15) |
| 2022 | $259.35 | 10 | Alkermes, Inc. ($92.91) |
| 2021 | $198.05 | 8 | Otsuka America Pharmaceutical, Inc. ($113.98) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: CNS | ||||||
| 10/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $33.96 | General |
| Category: Neuropsychiatry | ||||||
| 09/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Central Nervous System | ||||||
| 09/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Central Nervous System | ||||||
| 09/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $0.52 | General |
| Category: Central Nervous System | ||||||
| 08/27/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.43 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Neurology | ||||||
| 07/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Neuroscience | ||||||
| 07/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: Central Nervous System | ||||||
| 07/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: Central Nervous System | ||||||
| 07/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Central Nervous System | ||||||
| 07/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Central Nervous System | ||||||
| 07/02/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Neurology | ||||||
| 06/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: PSYCHIATRY | ||||||
| 06/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Central Nervous System | ||||||
| 06/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 68 | 163 | $52,160 | $6,244 |
| 2022 | 2 | 65 | 130 | $41,600 | $7,102 |
| 2021 | 2 | 56 | 98 | $31,360 | $6,074 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 121 | $38,720 | $4,996 | 12.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 42 | $13,440 | $1,249 | 9.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 110 | $35,200 | $5,585 | 15.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 20 | $6,400 | $1,517 | 23.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 67 | $21,440 | $3,774 | 17.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 31 | $9,920 | $2,300 | 23.2% |
About Charmaine Scott, APRN
Charmaine Scott, APRN is a Family healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2016. The National Provider Identifier (NPI) number assigned to this provider is 1780139782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Charmaine Scott, APRN has received a total of $2,527 in payments from pharmaceutical and medical device companies, with $1,094 received in 2024. These payments were reported across 122 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($2,417).
As a Medicare-enrolled provider, Scott has provided services to 189 Medicare beneficiaries, totaling 391 services with total Medicare billing of $19,420. Data is available for 3 years (2021–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Mental Health, Psychiatric/Mental Health
- Location Lauderhill, FL
- Active Since 08/19/2016
- Last Updated 06/19/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780139782
Products in Payments
- UZEDY (Drug) $337.19
- VRAYLAR (Drug) $299.84
- Austedo XR (Drug) $244.49
- INVEGA SUSTENNA (Drug) $236.01
- INGREZZA (Drug) $209.54
- REXULTI (Drug) $203.01
- CAPLYTA (Drug) $166.88
- HETLIOZ (Drug) $150.50
- ABILIFY MAINTENA (Drug) $139.68
- Auvelity (Drug) $124.99
- VIVITROL (Drug) $116.87
- AUSTEDO (Drug) $85.61
- ABILIFY ASIMTUFII (Drug) $81.36
- PERSERIS (Drug) $63.26
- ARISTADA (Drug) $48.00
- LYBALVI (Drug) $20.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lauderhill
Ms. Judith Vanwhervin, Fnp-Bc, FNP-BC
Family — Payments: $5,271
Rochelle Boyd, Arnp, ARNP
Family — Payments: $1,509
Danielle Cadenhead, Aprn, APRN
Family — Payments: $914.44
Sharon Salkey
Family — Payments: $427.93
Regine Barosy, Arnp, ARNP
Family — Payments: $327.05
Nadine Barreau, Aprn, APRN
Family — Payments: $259.56